Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 3,545 Shares of Stock

Posted by Francis Steltz on Aug 14th, 2026

Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) CEO Stephen Beard sold 3,545 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total value of $462,055.30. Following the transaction, the chief executive officer directly owned 415,197 shares of the company’s stock, valued at $54,116,776.98. This represents a 0.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Up 3.1%

CVSA opened at $132.20 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a 50 day simple moving average of $125.16. The firm has a market cap of $4.50 billion, a price-to-earnings ratio of 18.78, a P/E/G ratio of 0.95 and a beta of 0.62. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.19. The company had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts anticipate that Adtalem Global Education Inc. will post 8.99 earnings per share for the current year.

Institutional Trading of Adtalem Global Education

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CVSA. Truist Financial boosted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Finally, Barrington Research reiterated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Adtalem Global Education presently has an average rating of “Moderate Buy” and an average target price of $155.00.

Check Out Our Latest Research Report on CVSA

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.